Elanco Animal Health Inc 8-K

What Happened Elanco Animal Health Inc. (ELAN) filed a Form 8‑K on May 6, 2026 under Item 2.02 to report results of operations and financial condition. The company attached a press release dated May 6, 2026 as Exhibit 99.1, which is incorporated by reference into the 8‑K. The filing is signed by Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer.

Key Details

• Filing date: May 6, 2026 (Form 8‑K).
• Item disclosed: 2.02 — Results of Operations and Financial Condition.
• Exhibit 99.1: Press release issued by Elanco Animal Health dated May 6, 2026 (incorporated by reference).
• Filing also includes an Inline XBRL cover page (Exhibit 104.1) and is signed by CFO Robert M. VanHimbergen.

Why It Matters This 8‑K indicates Elanco has publicly disclosed recent operating and financial results via a press release. Retail investors should read the attached Exhibit 99.1 press release (and any subsequent filings such as the quarterly 10‑Q) for the specific earnings, revenue, and guidance details that could affect the stock. The filing confirms the company’s official disclosure and provides the interactive data file for financial analysis.